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Abstract
Investigations into human norovirus infection, replication and pathogenesis, as well as the development of potential
antiviral agents, have been restricted by the lack of a cell culture system for human norovirus. To date, the optimal cell
culture surrogate virus model for studying human norovirus biology is the murine norovirus (MNV). In this report we
generate a tetracycline-regulated, inducible eukaryotic cell system expressing the entire MNV ORF1 polyprotein. Once
induced, the MNV ORF1 polyprotein was faithfully processed to the six mature non-structural proteins that predominately
located to a discrete perinuclear region, as has been observed in active MNV infection. Furthermore, we found that
expression of the ORF1 polyprotein alone was sufficient to induce apoptosis, characterised by caspase-9 activation and
survivin down-regulation. This cell line provides a valuable new tool for studying MNV ORF1 non-structural protein function,
screening for potential antiviral agents and acts as a proof-of-principle for such systems to be developed for human
noroviruses.
Citation: Herod MR, Salim O, Skilton RJ, Prince CA, Ward VK, et al. (2014) Expression of the Murine Norovirus (MNV) ORF1 Polyprotein Is Sufficient to Induce
Apoptosis in a Virus-Free Cell Model. PLoS ONE 9(3): e90679. doi:10.1371/journal.pone.0090679
Editor: Yi Li, Wuhan Bioengineering Institute, China
Received August 20, 2013; Accepted February 4, 2014; Published March 5, 2014
Copyright:  2014 Herod et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Wellcome Trust, programme grant number 086112 entitled Replication of Noroviruses: Determinants of Tropism. The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: I.N.Clarke@soton.ac.uk
. These authors contributed equally to this work.
Introduction
Human norovirus infection is the leading cause of acute non-
bacterial gastroenteritis, with epidemics common in semi-enclosed
communities such as hospitals, schools and cruise ships. Currently,
there is no vaccine or anti-viral treatment for norovirus infection.
The lack of an efficient cell culture system for studying human
noroviruses [1] has limited studies on their infection, replication
and pathogenesis as well as the development of potential antiviral
treatments. Attempts to establish a human norovirus replicon
system have had limited application since the system was first
described in 2006 [2–4]. Most studies of human norovirus
molecular biology have focused on using purified proteins and
in vitro systems which are far removed from the cellular environ-
ment of viral infection [5–14].
Noroviruses belong to a genus within the calicivirus family of
single stranded positive-sense RNA viruses. The norovirus genome
is translated into three open reading frames (ORFs), termed
ORF1, ORF2 and ORF3 [15,16]. ORF1 encodes a single
polyprotein which is proteolytically cleaved into six viral non-
structural (NS) proteins (NS1/2, NS3, NS4, NS5, NS6 and NS7)
[10,17–25], whereas ORF2 and ORF3 encode the two viral
structural proteins, VP1 and VP2, respectively [26,27]. The ORF1
polyprotein encodes the viral NS6 protease which is responsible
for processing of the polyprotein at all five NS boundaries
[17,18,25] which follows a preferred temporal order [17,28].
Studies of ORF1 polyprotein processing in human noroviruses
primarily use in vitro models with heterologously expressed protein
or peptide substrate.
The majority of our knowledge on human norovirus biology is
drawn from studies with animal caliciviruses such as murine
norovirus (MNV). The MNV genome bears a high degree of
structural similarity to that of human norovirus, with the three
main ORFs encoded within the human norovirus genome having
a direct homologue in MNV (Figure 1). Additionally, the presence
of a 4th open reading frame, ORF4, has been indentified in MNV,
which seems to have no direct homologue in human noroviruses
[29], even though the presence of a non-equivalent 4th open
reading frame has been postulated within the genome of some
strains [30]. The pathogenesis of MNV infection is markedly
different from human noroviruses: human norovirus infection
typically results in acute gastroenteritis, whereas MNV infects
hematopoietic cells and is typically asymptomatic in immune-
competent mice [31,32]. Furthermore, in cellulo studies using MNV
infection also suffer from unco-ordinated expression and a
relatively short time window in which replication studies can be
conducted before cells undergo apoptosis [33]. Attempts to
establish MNV replicon systems have met with partial success,
only transient expression of genome replication has been
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demonstrated and no permanently transformed cell line has been
established [12].
Prior to the isolation of efficient cell culture models the study of
other non-culturable pathogens such as hepatitis C virus, was
advanced by the development of inducible eukaryotic cell models
expressing full-length polyprotein or polyprotein precursors. Such
models were subsequently used to study fundamental aspects of
hepatitis C virus biology and provided a useful tool in the
development of novel antiviral strategies in a well-defined and
reproducible cellular context [34,35].
Our aim was to establish an inducible eukaryotic cell system
that would allow detailed studies of norovirus polyprotein
processing without the need for infectious virus. As a proof-of-
principle, we introduced the MNV ORF1 polyprotein under
control of a tetracycline-regulated CMV promoter into HEK293
cells. We chose this approach since we could validate the system by
comparison with MNV infected cells. Following induction, the cell
clone, termed R1, expresses the full-length ORF1 polyprotein
which is proteolytically cleaved into the six mature viral NS
proteins. Immunofluorescence studies demonstrated NS1/2
through to NS5 proteins were found in a cellular localisation
similar to that previously observed with MNV infected RAW246.7
cells [36,37]. Approximately 16–24 hours post-induction cells
underwent apoptosis which was characterised by the activation of
caspase-9 and down-regulation of survivin, as has been previously
described for wildtype MNV infection [33]. This inducible model
of norovirus NS protein biosynthesis will provide a valuable tool
for studying MNV ORF1 polyprotein processing and NS protein
function in eukaryotic cells in the absence of viral infection and
provides proof-of-principle for authentic expression and processing
of norovirus NS proteins.
Materials and Methods
Plasmid Constructs
The tetracycline-inducible system for MNV ORF1 was
constructed using the T-REx tetracycline-regulated expression
system using component plasmid pcDNA6/TR (Invitrogen) with
plasmid pcDNA4/TO/MNV ORF1.
The tetracycline-regulated CMV driven polII expression
construct pcDNA4/TO/MNV ORF1 was derived from the T-
REx component plasmid pcDNA4/TO using standard molecular
cloning techniques in a three step process. Firstly, the C-terminal
NS7 region of the MNV ORF1 polyprotein was amplified by PCR
using primers 59-cccgtgcttttggccctttctgt and 59-ccccccgggccctcact-
catcctcattcacaaag with template pMNV* [38] until the 39 end of
ORF1 and incorporating an unique ApaI site. The XhoI-ApaI
digested PCR fragment was introduced into XhoI-ApaI digested
pcDNA4/TO (Invitrogen) to make pcDNA4/TO/MNV/S1
(Figure S1). Subsequently, the 3596 bp EcoRV-XhoI fragment
from pMNV*, representing the majority of ORF1 from the start of
NS3 until the XhoI site in NS7, was cloned into EcoRV-XhoI
digested pcDNA4/TO/MNV/S1 to create pcDNA4/TO/
MNV/S2 (Figure S2). Finally, PCR was used with primer pair
59-cccccctccggagtgaaatgaggatggcaacg and 59-agagccgagttggtg-
gaagc with pMNV* template, to amplify the N-terminal region
of the ORF1 polyprotein from the 59 end of MNV with flanking
BspEI site until the EcoRV site. The PCR fragment was digested
with BspEI and EcoRV and cloned into BspEI-EcoRV digested
pcDNA4/TO/MNV/S2 to create pcDNA4/TO/MNV ORF1
(Figure S3 and S4).
Cell Culture, Transfection and Infection
HEK293 cells (obtained from ATCC) were grown in DMEM
supplemented with 10% foetal calf serum and GlutaMAX-1
(Invitrogen).
Stable cell lines were produced using the T-REx tetracycline-
regulated expression system for mammalian cells (Invitrogen).
Transfection of HEK293 cells was performed using FuGENE HD
(Promega) using 2 mg of plasmid DNA and 5 ml of transfection
reagent per well. For selection of stable cell lines, transfected cells
were allowed to recover for 48 hours before selection with full
growth medium supplemented with 5 mg/ml blasticidin (Invitro-
gen) and/or 200 mg/ml zeocin (Invitrogen). For infections, 106
mouse macrophage RAW264.7 cells were seeded per well in a 12
well tray. Once the cells were attached, the cells were infected with
MNV-CW1 at an MOI= 1. Cells were incubated with the virus at
37uC for 90 minutes and then the media changed. Time points
were taken at 4, 8, 16, and 24 hours by scraping up the cells and
then processing with NucleoSpin RNA/Protein extraction kit
(Macherey-Nagel). Protein in a final volume of 100 ml was
produced, the protein concentration quantified by BSA assay
and equal quantities loaded onto 4–20% SDS-PAGE gels for
analysis.
SDS-PAGE and Western Blot
SDS-PAGE and Western blots were carried out as described
previously [38]. Primary antibodies used were rabbit polyclonals:
anti-NS1/2, anti-NS4, anti-NS5, anti-NS6 (all generated by Prof
Vernon Ward, University of Otago, using E.coli generated,
purified, whole NS protein antigens) and mouse anti-NS3 and
anti-NS7 monoclonals, (generated on our behalf by AbMART,
Shanghai, using NS protein-specific peptides). Proform and
cleaved caspase-9 was detected using an anti-caspase-9 mouse
monoclonal antibody, clone 96-2-22 (Merck Millipore). Survivin
was detected using an anti-survivin rabbit monoclonal antibody,
clone 71G4B7 (Cell Signalling Technology). Rabbit polyclonal
anti-GAPDH antibody (ab9485- Abcam) was used to demonstrate
gel loading, this antibody was used to probe both HEK293 cells
and MNV infected RAW264.7 cells, in the murine RAW264.7
Figure 1. Schematic representation of the MNV genome. The genome of murine norovirus 1 is shown annotated with the five dipeptide ORF1
polyprotein cleavage sites that are cleaved by the viral NS6 protease. The ORF1 polyprotein is cleaved into the six NS proteins termed NS1/2, NS3,
NS4, NS5, NS6 and NS7. Also indicated are the alternative names for each non-structural protein, N-term though to 3D.
doi:10.1371/journal.pone.0090679.g001
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cells it had a high background. Goat anti-rabbit and goat anti-
mouse HRP conjugates (Sigma-Aldrich) were employed as
secondary reagents.
Confocal Microscopy
R1 cells seeded onto polylysine coated glass coverslips were
induced with 0.25 mg/ml tetracycline for 1 hour or left uninduced,
fixed at timepoints between 2 and 24 hours post-induction in 4%
paraformaldehyde, washed in PBS and permeabilised in saponin
buffer (0.1% saponin, 10% foetal calf serum, 0.1% sodium azide)
for 1 hour at 4uC. Primary and secondary antibodies were
incubated in saponin buffer for 1 hour at room temperature and
washed in saponin buffer between steps. Primary antibodies used
were as described in western blotting (above) and were detected
with anti-rabbit-Alexa488 or anti-mouse-Alexa488 conjugate
(Invitrogen) secondaries. Cells were counterstained with 1 mg/ml
DAPI (Fisher Scientific), washed a final time in PBS and mounted
onto slides with ProLongGold (Invitrogen). Images were captured
using a Leica TCP SP5 confocal microscope.
Fluorescent Apoptosis Staining
To differentiate between apoptotic and non-apoptotic path-
ways, cells were stained with the Vybrant Apoptosis Assay
(Invitrogen), following manufacturer’s protocol with slight modi-
fication. R1 cells seeded onto polylysine coated glass coverslips
were induced with 0.25 mg/ml tetracycline (Sigma-Aldrich) for 1
hour or left uninduced and at timepoints between 12 and 24 hours
post-induction stained with YO-PRO-1 and propidium iodide
diluted in full growth medium, on ice for 30 minutes. Coverslips
were mounted onto slides using PBS and imaged immediately
using a Leica Leitz-DMRB fluorescent microscope with camera.
Results
A Stable Cell Clone Expressing MNV ORF1
To establish a virus-free model for studying MNV ORF1
processing we utilised the commercial TREx tetracycline (Tet) -
regulated dual plasmid expression system. This system uses the
pcDNA6/TR regulatory plasmid which constitutively expresses
the Tet repressor gene to repress expression from the expression
plasmid, pcDNA4/TO, which was engineered to express the
MNV ORF1 polyprotein (Figure 2). In the absence of tetracycline,
Tet repressor homodimers bind to the Tet operator sequences
present in the vector to repress MNV ORF1 expression. Upon
addition, Tet binds to repressor homodimers, releasing the
repressor from the operator sequences and de-repressing expres-
sion of MNV ORF1.
Set up of this system first required selection of a cell line stably
expressing the Tet repressor, with the requirement that the cell
line chosen must also support MNV replication. Attempts to select
a stable RAW264.7 or BHK-21 cell line expressing the Tet
repressor were unsuccessful after multiple attempts (data not
shown). However, HEK293 clones which expressed the Tet
repressor were readily selectable after transfection with pcDNA6/
TR and culture in the presence of blasticidin for 2 weeks.
Following clonal expansion in the presence of blasticidin, the
repressor cell line stably expressing the Tet repressor was
transfected with the Tet responsive MNV ORF1 expressing
plasmid, pcDNA4/TO/MNV ORF1. Transformants were select-
ed for two weeks in the presence of blasticidin and zeocin and
clonally expanded for a further 4 weeks. Six individual stable
clones were screened for MNV ORF1 translation products by
Western blot and a single clone, termed R1, was selected based on
high level expression of the NS1/2 and NS7 proteins (data not
shown).
The ORF1 Polyprotein is Processed to Completion in the
Absence of Viral Genomic RNA
In MNV infection the ORF1 polyprotein is processed to
completion by the NS6 protease, yielding the mature viral NS
proteins in equal amounts. To establish whether processing of the
ORF1 polyprotein goes to completion in the R1 cell clone,
induced and uninduced cells were harvested at time points of 2, 4,
8, 16 and 24 hours post-induction and lysates probed by Western
blot using antibodies against MNV NS proteins (Figure 3A). For
comparison an equivalent time course was conducted with MNV
infected cells and NS protein expression probed by Western blot
(Figure 3B). Expression of most, fully cleaved, mature NS proteins
could clearly be detected in the R1 cell line by 16 hours post-
induction. In an active MNV infection expression of NS1/2, NS3,
NS4 and NS7 could be easily detected from 16 hours post-
infection while NS6 was only abundant at 24 hours post-infection.
Furthermore, the molecular weight of all fully cleaved NS proteins
expressed in the R1 cell line corresponded to the molecular weight
as observed in MNV infected RAW264.7 cells. No significant
amounts of uncleaved precursors could be detected with these
antibodies within the R1 cell line or MNV infection at any time
points even after over development except for NS5 (data not
shown). Interestingly, between 22–24 hours post-induction, R1
cells underwent synchronised cell death to become detached from
the surface, accounting for the lower protein concentration and
the apparent reduced protein expression at the 24 hour time point.
Cellular localisation of ORF1 Proteins
Upon induction with tetracycline, the R1 clone demonstrated
complete processing of the ORF1 polyprotein with mature NS
proteins clearly detectable by 16 hours post-induction. Previous
studies have defined the cellular localisation of MNV NS proteins
expressed both individually by transfection of cDNA and in active
MNV infection [36,37,39]. To determine the localisation of NS
proteins in the R1 cell clone, induced and uninduced R1 cells on
coverslips were fixed at equal time points 2–20 hours post-
induction. The coverslips were individually labelled with antibod-
ies against NS proteins and analysed by immunofluorescence
(Figure 4). By 8 hours post-induction, NS1/2, NS3, NS4 and NS5
all localised to a discrete perinuclear region with little diffuse
cytoplasmic staining. In contrast, NS6 demonstrated diffuse
cytoplasmic staining at all time points with no defined perinuclear
localisation apparent. Our antisera to NS7 did not work in
immunofluoresecence.
Expression of MNV ORF1 is Sufficient to Induce Apoptosis
The R1 cells underwent synchronised cell death approximately
20–24 hours post-induction. MNV infection of RAW264.7 cells
results in apoptosis beginning at 12–16 hours post-infection and
eventually leading to cell death approximately 24 hours post-
infection. MNV induced apoptosis is associated with activation of
caspase-9, caspase-3, down-regulation of survivin and apoptosis
through the mitochondrial pathway [33]. To determine whether
the same events were responsible for the cell death observed with
induced R1 cells it was first necessary to confirm the R1 cell death
was attributed to apoptosis. Induced and uninduced R1 cells were
therefore stained with the Vybrant Apoptosis Assay kit at time
points between 12–24 hours post-induction and visualised by
immunofluorescence (Figure 5A). With this system cells undergo-
ing apoptosis exhibit bright green fluorescence and necrotic cells
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are labelled orange. Upon induction R1 cells underwent partially
synchronised apoptosis, beginning at 16–18 hours post-induction
and peaking at 20 hours post-induction. At times beyond 22 hours
post-induction most cells had died and become detached from the
surface.
To identify whether the observed apoptosis was associated with
caspase-9 activation and survivin down-regulation (as has been
observed with MNV infection [33]), induced or uninduced R1
cells were harvested at timepoints between 8 and 22 hours post-
induction and lysates probed by Western blot using anti-caspase-9
and anti-survivin monoclonal antibodies (Figure 5B and 5C).
Figure 2. Schematic representation of the tetracycline-regulated ORF1 expression system. In the absence of tetracycline (Tet) (A) Tet
repressor protein (TetR) homodimers, expressed constitutively from pcDNA6/TR, bind to the Tet operator 2 (TetO2) sequences in the inducible ORF1
expression vector (pcDNA4/TO/MNV ORF1) to repress transcription of the MNV ORF1 polyprotein. Upon the addition of Tet (B) Tet binds to TetR
homodimers, resulting in a conformational change, releasing it from the TetO2 sequences allowing expression of the MNV ORF1 polyprotein.
doi:10.1371/journal.pone.0090679.g002
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Caspase-9 activation could only be detected in induced R1 cells, at
16 hours post-induction as indicated by the cleaved caspase-9
product of approximately 37 kDa by Western blot. By 22 hours
post-induction most of the cells had detached from the surface,
therefore resulting in a lower protein concentration in this sample
and reduced protein loading. In MNV infected RAW264.7 cells
survivin down-regulation begins at approximately 8 hours post-
infection [33]. Concordant with this study, down-regulation of
survivin can clearly be observed in induced R1 cells at 8 hours
post-induction and is maintained down-regulated up to 22 hours
post induction.
Discussion
Our aim was to construct a human cell line capable of inducible
expression of norovirus non-structural proteins (ORF1). We
describe a stable cell line expressing the MNV ORF1 polyprotein
under control of a tightly-regulated inducible tetracycline gene
expression system. At the start of this study, attempts to select
stable transformants were performed with three well characterised
cell lines, RAW264.7, BHK-21 and HEK293. These cell lines
were chosen based on their relatively high transfection efficiencies,
and because it is possible to recover MNV from all three cell lines
following transfection with full-length viral cDNA [38,40]. Despite
multiple attempts, we were unable to select stable cell lines with
RAW264.7 and BHK-21 cells. In contrast, stable HEK293
transformants were readily selectable and an individual clone,
termed R1, was chosen for characterisation based on high
expression of the non-structural proteins at 59 and 39 end of the
ORF1 polyprotein, NS1/2 and NS7, respectively.
Upon induction, the MNV ORF1 polyprotein was processed to
completion, similar to the processing seen in MNV infection [25].
Expression of the N-terminal ORF1 protein, NS1/2, was just
detectable after only 2 hours post-induction, closely followed by
NS3, NS4 and NS7 detectable after 4 hours and NS6 at 8 hours
post-induction, with expression peaking at approximately 8–16
hours. For each NS protein the time course of expression in R1
cells was faster than that observed in MNV infected RAW264.7
cells. However, there was little difference in the final relative
amount of each NS protein expressed in the R1 cells and an active
MNV infection run in parallel and using the same reagents for
immune detection. The early, high level expression of the MNV
ORF1 polyprotein from the CMV promoter in the R1 clone
allows for greater initial synthesis of viral NS protein compared to
a natural infection (where viral genome amplificiation has to occur
before high-level protein expression is achieved) and as a result
may contribute to the induction of apoptosis observed in R1 cells.
Mature cleavage products were readily detectable in both wild
type MNV infection and the induced R1 clone. It is likely that
complete processing of the ORF1 polyprotein is essential for viral
RNA replication, making the protease an attractive target for anti-
viral therapy. The apparent processing to completion of the ORF1
Figure 3. Western blot analysis of NS protein expression in the R1 cell clone and in MNV-1 infected RAW264.7 cells. A. The R1 cell line
was induced with 0.25 mg/ml tetracycline or uninduced. B. RAW264.7 cells were infected with MNV with an MOI = 1.0. In both cases cells were
harvested at 2, 4, 8, 16 and 24 hours post-induction/post infection, total protein quantified by BCA assay and 10 mg of each lysate analysed by
Western blotting for expression of MNV NS proteins as indicated. In panel A, lysates were analysed by single concentration SDS PAGE. In panel B, 4–
20% gradient SDS-PAGE was used, accounting for variations in relative migration of some of the molecular weight markers to those in panel A.
doi:10.1371/journal.pone.0090679.g003
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polyprotein in R1 cells clearly demonstrates that the NS6 protease
retains activity in this model system. The R1 cell line will therefore
provide a useful tool for evaluating potential protease inhibitors in
a tightly regulated, reproducible, eukaryotic system that is free
from viral replication where secondary factors such as unco-
ordinated expression can have interfering effects.
In RAW264.7 cells all MNV NS proteins locate to a distinct
perinuclear region along with dsRNA and it is thought to be the
location of viral RNA replication [36,37]. In our model system the
first four NS proteins, NS1/2, NS3, NS4 and NS5, all located to a
perinuclear region similar to that observed in MNV-infected
RAW246.7 cells. In contrast, NS6 demonstrated largely diffuse,
cytoplasmic fluorescence with no distinguishable perinuclear
localisation.
Following induction of the ORF1 polyprotein R1 cells undergo
cell death and become detached from the surface after approx-
imately 24 hours, which was not observed in uninduced R1 cells or
an inducible HEK293 cell line expressing b-galactosidase (data not
Figure 4. Localisation of MNV NS proteins when expressed in HEK293 cells. R1 cells were induced with 0.25 mg/ml tetracycline and fixed at
2, 4, 8, 16 and 24 hours post-induction before being labelled with antisera specific to MNV NS proteins (green) and cell nuclei were counterstained
(blue). Images were captured by confocal microscopy. Scale bar is 25 mm.
doi:10.1371/journal.pone.0090679.g004
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shown). The observed ORF1 related cell death was characterised
by induction of apoptosis at approximately 16 hours post-
induction and associated with the activation of caspase-9 and
down-regulation of survivin. These observations are in agreement
with previous findings where it was shown that MNV replication
triggered apoptosis in infected RAW264.7 cells at 12–16 hours
post-infection, through the activation of caspase-9, caspase-3 and
was associated with a down-regulation of survivin (an inhibitor of
apoptosis which prevents activation of caspase-9). Furthermore,
both UV inactivation of virus or treatment with cycloheximide
eliminated apoptosis and the expression of individual structural or
non-structural proteins was shown not to result in down-regulation
of survivin, suggesting active viral replication was required to
induce apoptosis [33]. Here we report that only expression of the
MNV ORF1 polyprotein is sufficient to induce survivin down-
regulation and apoptosis in the complete absence of viral genome
or viral genome replication. Taking these data together, it seems
likely that the survivin down-regulation and induction of apoptosis
is mediated by one or more ORF1 polyprotein products, but not
by a single NS protein expressed alone or by viral genome
replication. However, it is unclear whether this may be the effect of
several mature non-structural proteins working in co-operation
and/or transient ORF1 polyprotein precursor products.
It is not known what role apoptosis and programmed cell death
may play in MNV infection. In RAW264.7 cells MNV infection
clearly causes apoptosis and programmed cell death, most likely
through an atypical pathway involving survivin and possibly other
players such as cathepsin B [33,41]. Blocking apoptosis using a
pan-caspase inhibitor both accelerated cell death and changed the
death pathway to typical necrosis, while resulting in an over 10-
fold reduction in infectious virion production [41]. It was therefore
suggested MNV has adapted a strategy to allow apoptosis to
proceed and thus provide a larger time window for virus
replication. Alternatively, activation of caspases may provide a
vital role in the viral replication process. The MNV ORF1 N-
terminal protein, NS1/2, has been shown to be processed by
caspase-3 into two fragments of 13.6 and 24.7 kDa [25], the first of
which contains the majority of the disordered region [42]. The
function of the NS1/2 protein is not known and it is likely to
perform multiple roles during replication. However, it is possible
that cleavage of the NS1/2 protein by activated caspase-3 may be
a functional requirement of this protein.
In the absence of a human norovirus cell culture system most of
our knowledge of norovirus molecular biology comes from studies
with MNV. There is a human norovirus replicon system but this
suffers from low level replication and an absence of mature ORF1
polyprotein cleavage products hindering certain approaches such
Figure 5. Expression of the MNV ORF1 polyprotein is sufficient to induce apoptosis in HEK293 cells. (A) R1 cells were seeded onto glass
coverslips, induced with tetracycline and at 14, 16, 18, 20, 22 and 24 hours post-induction, stained with YO-PRO-1 (green) and propidium iodide
(orange) and visualised by fluorescence microscopy. Western blot analysis of induced or uninduced R1 cells harvested at 4, 8, 16 and 24 hours post-
induction for caspase-9 activation (B) or at 8, 16, 20 and 22 hours for survivin expression (C). For each lysate total protein quantification was
performed by BCA assay and 50 mg of protein loaded per lane. Due to low protein concentration in the induced 24 hour sample approximately 100-
fold less protein was loaded.
doi:10.1371/journal.pone.0090679.g005
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as pulse chase analyses and the development of protease inhibitors.
By contrast the inducible norovirus R1 cell line described here is
ideal for such studies which require co-ordinated high level
expression and is well suited for applications such as high
throughput enzyme inhibitors testing. In addition, the well-defined
cellular architecture of the parental HEK293 cells used to establish
the R1 cell line makes them easier to use than MNV infected
RAW264.7 cells which have a smaller cytoplasm and less well
defined cellular features.
In conclusion, we have established and characterised a stable
cell line with tightly regulated inducible expression of the MNV
ORF1 polyprotein which is processed into mature non-structural
proteins. This cell line will provide a valuable tool for studying
polyprotein processing and non-structural protein function in
eukaryotic cells, for screening for novel protease inhibitors and
provides a proof-of-principle for similar systems to be established
with non-culturable human noroviruses.
Supporting Information
Figure S1 Map of plasmid pcDNA4/TO/MNV/S1. PCR
was used to amplify the ORF1 C-terminal region from pMNV*
from upstream of the XhoI site until the 39 end and incorporating a
downstream ApaI site. The XhoI-ApaI digested PCR fragment was
ligated into XhoI-ApaI digested pcDNA4/TO at the multiple
cloning site to create pcDNA4/TO/MNV/S1.
(TIF)
Figure S2 Map of plasmid pcDNA4/TO/MNV/S2.
Plasmid pcDNA4/TO/MNV/S2 was created by ligating the
EcoRV-XhoI fragment from pMNV*, representing the large central
portion of the MNV ORF1 region, into EcoRV-XhoI digested
pcDNA4/TO/MNV/S1 to give pcDNA4/TO/MNV/S2.
(TIF)
Figure S3 Map of plasmid pcDNA4/TO/MNV ORF1.
Plasmid pcDNA4/TO/MNV ORF1 was created by PCR
amplifying the ORF1 N-terminal region of pMNV* with flanking
upstream BspEI site until the EcoRV site and ligating the BspEI-
EcoRV PCR fragment into BspEI-EcoRV digested pcDNA4/TO/
MNV/S2.
(TIF)
Figure S4 Plasmid pcDNA4/TO/MNV ORF1 features
table and sequence. The main features of plasmid pcDNA4/
TO/MNV ORF1 are shown with the nucleotide co-ordinates and
the full plasmid nucleotide sequence.
(DOC)
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